KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Prepaid Assets: 2011-2025

Historic Prepaid Assets for Supernus Pharmaceuticals (SUPN) over the last 14 years, with Sep 2025 value amounting to $62.1 million.

  • Supernus Pharmaceuticals' Prepaid Assets rose 126.53% to $62.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.1 million, marking a year-over-year increase of 126.53%. This contributed to the annual value of $36.1 million for FY2024, which is 116.41% up from last year.
  • Supernus Pharmaceuticals' Prepaid Assets amounted to $62.1 million in Q3 2025, which was up 97.60% from $31.4 million recorded in Q2 2025.
  • In the past 5 years, Supernus Pharmaceuticals' Prepaid Assets registered a high of $62.1 million during Q3 2025, and its lowest value of $15.8 million during Q4 2022.
  • Over the past 3 years, Supernus Pharmaceuticals' median Prepaid Assets value was $27.4 million (recorded in 2024), while the average stood at $30.4 million.
  • As far as peak fluctuations go, Supernus Pharmaceuticals' Prepaid Assets tumbled by 48.25% in 2024, and later soared by 126.53% in 2025.
  • Quarterly analysis of 5 years shows Supernus Pharmaceuticals' Prepaid Assets stood at $27.0 million in 2021, then tumbled by 41.60% to $15.8 million in 2022, then grew by 5.68% to $16.7 million in 2023, then skyrocketed by 116.41% to $36.1 million in 2024, then skyrocketed by 126.53% to $62.1 million in 2025.
  • Its last three reported values are $62.1 million in Q3 2025, $31.4 million for Q2 2025, and $28.9 million during Q1 2025.